Clinical Trials · NCT01667900
A Study of Dulaglutide in Chinese Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 58
- Start date
- Aug 2012
- Locations
- 1 site, China
- Primary endpoint
- Pharmacokinetics: Maximum Concentration (Cmax) of Dulaglutide